Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.140
-1.160-3.29%
Volume:15.59M
Turnover:537.10M
Market Cap:207.02B
PE:31.37
High:34.660
Open:34.480
Low:33.640
Close:35.300
52wk High:43.587
52wk Low:27.658
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.98
T/O Rate:0.26%
Dividend:0.50
Dividend Rate:1.45%
EPS(LYR):1.088
ROE:19.40%
ROA:9.08%
PB:4.68
PE(LYR):31.37
PS:11.13

Loading ...

Hansoh Pharmaceutical Group Stock Rallies 2.6% in Hong Kong

Dow Jones
·
Jun 12

Hansoh Pharma posts 80% MMR at week 48 in phase 1b HS-10382 plus flumatinib trial for newly diagnosed CML-CP

Reuters
·
Jun 12

Hansoh Pharmaceutical Group (SEHK:3692) Valuation Check After Hang Seng China Enterprises Index Inclusion

Simply Wall St.
·
Jun 11

Hansoh Pharma Appoints Guo Ying as Joint Company Secretary Following Zhong Shengli’s Resignation

Bulletin Express
·
Jun 10

Hansoh Pharma’s NDA for HS-10568 Injection Accepted by China’s NMPA

Bulletin Express
·
Jun 10

HANSOH PHARMA Receives NMPA Acceptance for New Drug Application of HS-10568 Injection

Stock News
·
Jun 10

Hansoh Pharma says China regulator accepts NDA for HS-10568 injection in kidney disease complication

Reuters
·
Jun 10

Hansoh Pharmaceutical - Nda for Hs-10,568 Injection Accepted by Nmpa of China for Shpt in Adult Ckd Patients

THOMSON REUTERS
·
Jun 10

HANSOH PHARMA Announces Appointment of Guo Ying as Joint Company Secretary

Stock News
·
Jun 10

Hansoh Pharmaceutical Group Stock Rises 2.6% in Hong Kong

Dow Jones
·
Jun 10

Hansoh Pharmaceutical Group Stock Falls 1.8% in Hong Kong

Dow Jones
·
Jun 08

Hansoh Pharmaceutical Group Stock Sheds 1.6% in Hong Kong

Dow Jones
·
Jun 05

HANSOH PHARMA Shares Surge on New Drug Application Acceptance

Stock News
·
Jun 05

Hansoh Pharma seeks shareholder approval for 2026 share option and award scheme

Reuters
·
Jun 04

Hansoh Pharma announces annual general meeting notice

Reuters
·
Jun 04

Hansoh Pharmaceutical's Weight-loss Injection Enters China Review

MT Newswires Live
·
Jun 04

BRIEF-Hansoh Pharmaceutical Says NDA For Olatorepatide Injection Accepted By China's NMPA

Reuters
·
Jun 04

HANSOH PHARMA's Obesity Drug Application Accepted by Chinese Regulator

Stock News
·
Jun 04

Hansoh Pharma says China regulator accepts NDA for olatorepatide weight management injection

Reuters
·
Jun 04

Hansoh Pharmaceutical - Nda for Olatorepatide Injection Accepted by Nmpa of China for Chronic Weight Management

THOMSON REUTERS
·
Jun 04